For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising ...

Trump officials are capitalizing on lingering COVID resentment to undermine American vaccine policy.

The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.